Loss of DDB2 in type II diabetes mellitus induces dysregulated ubiquitination of KMT2A in lipid metabolism disorders
The Journal of Steroid Biochemistry and Molecular Biology · 2025
DOI: 10.1016/j.jsbmb.2025.106673 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2025. Verfasst von Lvqiu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, the Second People's Hospital of Kunming, Kunming, Yunnan 650203, PR China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, DNA-Binding Proteins, Histone-Lysine N-Methyltransferase, Lipid Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The disorders of glucose and lipid metabolism contribute to severe diseases, including cardiovascular disease, diabetes, and fatty liver. Here, we identified DNA damage-binding protein 2 (DDB2), an E3 ubiquitin ligase, as a pivotal regulator of lipid metabolism disorders in type II diabetes mellitus (T2DM). A mouse model of T2DM and primary mouse hepatocytes with steatosis were induced. DDB2 overexpression alone or in combination with lysine N-methyltransferase 2 A (KMT2A) overexpression vectors were delivered into db/db mice and in vitro hepatocytes. DDB2 was expressed poorly, while KMT2A was expressed highly in liver tissues and primary hepatocytes of db/db mice. DDB2 ameliorated glucose intolerance and insulin resistance, decreased liver/body weight ratio, downregulated expression of lipogenesis-associated proteins (SREBP1, FASN, and SCD1) and gluconeogenesis-related proteins (PEPCK and G6Pase) in liver tissues and cells, and decreased triglyceride and total cholesterol levels in steatotic hepatocytes. DDB2 reduced KMT2A expression through ubiquitination modification. Overexpression of KMT2A promoted insulin resistance, lipogenesis and lipid deposition, and glycogen accumulation in the presence of DDB2. Overall, our data demonstrate that DDB2 alleviates hepatic lipogenesis and lipid deposition via degradation of KMT2A, thereby repressing lipid metabolism disorders in T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, the Second People's Hospital of Kunming, Kunming, Yunnan 650203, PR China.
- Department of Orthopaedic Trauma, Baoshan People's Hospital, Baoshan, Yunnan 678000, PR China.
- Department of Endocrinology, the Second People's Hospital of Kunming, Kunming, Yunnan 650203, PR China. Electronic address: Wuyang3166@163.com.
Zitieren
APA
Li, L., Yang, M., Tan, L., Ni, Y., & Wu, Y. (2025). Loss of DDB2 in type II diabetes mellitus induces dysregulated ubiquitination of KMT2A in lipid metabolism disorders. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2025.106673
Vancouver
Li L, Yang M, Tan L, Ni Y, Wu Y. Loss of DDB2 in type II diabetes mellitus induces dysregulated ubiquitination of KMT2A in lipid metabolism disorders. The Journal of Steroid Biochemistry and Molecular Biology. 2025. doi:10.1016/j.jsbmb.2025.106673
BibTeX
@article{Li2025,
author = {Li, Lvqiu and Yang, Maogeng and Tan, Longqiao and Ni, Yanhong and Wu, Yang},
title = {Loss of DDB2 in type II diabetes mellitus induces dysregulated ubiquitination of KMT2A in lipid metabolism disorders},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
year = {2025},
doi = {10.1016/j.jsbmb.2025.106673}
}
EUVIMED